BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 17934347)

  • 1. New therapies for immune thrombocytopenic purpura.
    Andemariam B; Bussel J
    Curr Opin Hematol; 2007 Sep; 14(5):427-31. PubMed ID: 17934347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of immune thrombocytopenic purpura in adults.
    Bussel J
    Semin Hematol; 2006 Jul; 43(3 Suppl 5):S3-10; discussion S18-9. PubMed ID: 16815346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab: a new therapeutic tool for primary immune thrombocytopenic purpura?
    Introna M; Golay J; Barbui T
    Haematologica; 2003 May; 88(5):482-4. PubMed ID: 12745265
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis, pathophysiology and management of children with refractory immune thrombocytopenic purpura.
    Kalpatthi R; Bussel JB
    Curr Opin Pediatr; 2008 Feb; 20(1):8-16. PubMed ID: 18197033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN; Kozuch P; Varma M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of therapies for immune thrombocytopenic purpura.
    Bussel J; Tarantino M
    Semin Hematol; 2006 Jul; 43(3 Suppl 5):S1-2. PubMed ID: 16815344
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenesis of chronic immune thrombocytopenic purpura.
    Cines DB; McMillan R
    Curr Opin Hematol; 2007 Sep; 14(5):511-4. PubMed ID: 17934360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical issues of current and future developments in the treatment of immune thrombocytopenic purpura.
    Koene HR
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):703-5. PubMed ID: 16933273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?
    Cooper N; Evangelista ML; Amadori S; Stasi R
    Curr Opin Hematol; 2007 Nov; 14(6):642-6. PubMed ID: 17898569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of an infant with severe acute refractory immune thrombocytopenic purpura using combination therapy including rituximab.
    Iesato K; Hatakeyama N; Yamamoto M; Hori T; Inazawa N; Tsutsumi H; Suzuki N
    Pediatr Blood Cancer; 2009 Aug; 53(2):203-5. PubMed ID: 19301247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current options for the treatment of idiopathic thrombocytopenic purpura.
    Arnold DM; Kelton JG
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune thrombocytopenic purpura in adults.
    Godeau B; Provan D; Bussel J
    Curr Opin Hematol; 2007 Sep; 14(5):535-56. PubMed ID: 17934364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab.
    Kuwana M; Iki S; Urabe A
    Am J Hematol; 2007 Sep; 82(9):846-8. PubMed ID: 17506067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New treatment options for immune-mediated hematological disorders.
    Dierickx D; De Rycke A; Vanderschueren S; Delannoy A
    Eur J Intern Med; 2008 Dec; 19(8):579-86. PubMed ID: 19046722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia.
    Cooper N
    Hematol Oncol Clin North Am; 2009 Dec; 23(6):1317-27. PubMed ID: 19932436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the management of immune thrombocytopenic purpura in children.
    Tarantino MD; Bolton-Maggs PH
    Curr Opin Hematol; 2007 Sep; 14(5):526-34. PubMed ID: 17934363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights and therapeutics for immune-mediated thrombocytopenia.
    Metjian A; Abrams CS
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):71-84. PubMed ID: 18095908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunologic thrombocytopenic purpura: a revolution of biological therapy?].
    Bierling P; Godeau B
    Rev Prat; 2009 May; 59(5):606-7. PubMed ID: 19552194
    [No Abstract]   [Full Text] [Related]  

  • 20. Idiopathic thrombocytopenic purpura.
    Palaniappan G; Jennings W
    Mo Med; 2009; 106(1):69-73. PubMed ID: 19245128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.